THE IMPORTANCE OF THE FACTOR OF OVERWEIGHT AND OBESITY IN THE EPIDEMIOLOGY OF BREAST CANCER


如何引用文章

全文:

详细

The paper deals with the problem of overweight that is a risk factor for breast cancer in women. The drastic rise in adiposity in North America, Europe, and the Russian Federation in the last decade is accompanied by a steady increase in breast cancer morbidity. In our study, more than 75% of patients had varying overweight and obesity. The average body mass index for patients with the aggressive edematous forms of breast cancer is higher than that for those with its nodular forms that have a more favorable prognosis.

全文:

受限制的访问

作者简介

Е. SARYBEKYAN

P.A. Herzen Moscow Oncology Research Institute, Ministry of Health and Social Development of Russia

Email: mammolog3@yandex.ru

M. ERMOSHCHENKOVA

P.A. Herzen Moscow Oncology Research Institute, Ministry of Health and Social Development of Russia

参考

  1. Злокачественные новообразования в России в 2009 году (заболеваемость и смертность) / Под ред. В.И. Чиссова, В.В. Старинского, Г.В. Петровой. М. 2011.
  2. Рак молочной железы / Под ред. Н.Е. Кушлинского, С.М. Портного К.П. Лактионова М.: Издательство РАМН. 2005.
  3. Берштейн Л.М. Гормональный канцерогенез. СПб. 2000.
  4. Chetrite G.S., Cortes-Prieto J., Philippe J.C. et al. Comparison of estrogen concentrations, estrone sulfatase and aromatase activities in normal, and in cancerous, human breast tissues. J. Steroid. Biochem. Mol. Biol. 2000; 72: 23-27.
  5. Telang N.T., Suto A., Wong G.Y. et al. Induction by estrogen metabolite 16-alpha-hydroxyestrone of genotoxic damage and abberant proliferation in mouse mammary epithelial cells. J. Natl. Cancer Inst. 1992: 84: 634-638.
  6. Adlercreutz H., Gorbach S.L., Goldin B.R. et al. Estrogen metabolism and excretion in оriental and сaucasian women. J. Natl. Cancer Inst. 1994; 86: 1076-1082.
  7. Van den Brandt P.A., Spiegelman D., Yaun S. et al. Рооled analysis of prospective cohort studies jn height,weigt and breast cancer risk. Am. J. Epidemiol. 2000; 152: 514-527.
  8. Семиглазов В.Ф., Семиглазов В.В., Клетсель А.Е. Неоадьювантное и адьювантное лечение рака молочной железы. М.: ООО «МИА». 2008. 13-23.
  9. Lahmann P.H., Gullberg B., Olsson H. et al. Birth weight is associated with postmenopausal breast cancer risk in Swedish women. Br. J. Cancer. 2004; 91(9): 1666-1668.
  10. Yang W.T., Le-Petross H.T., Macapinlac H. et al. Inflammatory breast cancer: PET/CT, MRI, mammography, and sonography findings. Br. Cancer Res. Treat. 2007. Electronic online version.
  11. Nakhlis F., Duggan M.,. Golshan M. et al.. Preclinical breast MRI findings in inflammatory breast carcinoma/. ASCO Meeting Abstracts. 2005; 23: 899.
  12. Янишевский Ф.И. Рак молочной железы. М.:Медицина. 1966; 331.
  13. Дорофеев А.В. Оптимизация диагностики и лечения больных отечно-инфильтративным раком молочной железы: Автореф. дис.… д-ра. мед. наук.Уфа. 2003.
  14. Chang S., Buzdar A.U., Hursting S.D. Inflammatory breast cancer and body mass index. Department of еpidemiology, The University of Texas M.D. Anderson Cancer Center, Houston 77030-4095, USA. Electronic online version.

补充文件

附件文件
动作
1. JATS XML
##common.cookie##